PRECISE v2: An Enhanced Framework To Guide Future Research on the Use of Magnetic Resonance Imaging in Prostate Cancer Active Surveillance
-
Published:2024-09
Issue:3
Volume:86
Page:256-257
-
ISSN:0302-2838
-
Container-title:European Urology
-
language:en
-
Short-container-title:European Urology
Author:
Cooperberg Matthew R.ORCID
Reference13 articles.
1. Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer—2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.03.027.
2. Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up;Eastham;J Urol,2022
3. Refined analysis of prostate-specific antigen kinetics to predict prostate cancer active surveillance outcomes;Cooperberg;Eur Urol,2018
4. Randomized study of systematic biopsy versus magnetic resonance imaging and targeted and systematic biopsy in men on active surveillance (ASIST): 2-year postbiopsy follow-up;Klotz;Eur Urol,2020
5. Mutiparametric magnetic resonance imaging alone is insufficient to detect grade reclassification in active surveillance for prostate cancer;Chu;Eur Urol,2020